Cognitive Processing Therapy Versus Medication for the Treatment of Comorbid Substance Use Disorder and Post-Traumatic Stress Disorder in Egyptian patients (Randomized Clinical Trial)
Journal of Evidence-Based Psychotherapies · 01.09.2022 · 22 (2) · 63-90
DOI: 10.24193/jebp.2022.2.13 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Evidence-Based Psychotherapies, online erschienen am 01.09.2022. Verfasst von Amani ELBARAZI und 3 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 87 Literaturangaben.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
"Earlier research has established that posttraumatic stress disorder (PTSD) and substance use disorder (SUD) frequently coexist.
Aims
Cognitive Processing Therapy was compared to Sertraline and a placebo in an RCT for treating patients with comorbid SUD and PTSD.
Methods
150 patients with SUD and PTSD were interviewed by clinicians and asked to fill out the Clinician-Administered PTSD Scale (CAPS-5), Posttraumatic Stress Disorder Checklist (PCL-5), Beck Depression Inventory (BDI-II), Timeline Follow Back Interview (TLFB), and Brief Addiction Monitor (BAM). Patients were randomly assigned to the following conditions: CPT (n=50), Sertraline (n=50), or Placebo (n=50). Pretreatment, posttreatment, six and, twelve-month follow-up assessments were conducted.
Results
When compared to the sertraline group, CPT resulted in much higher reductions in CAPS scores at posttreatment assessment (d=0.93, p < .000). When compared to the control group, CPT considerably reduced PTSD symptoms (the effect size, d=1.9, p < .000). Sertraline resulted in many significant decreases in CAPS when compared to control groups (the effect size , d=1.11, p
Zitieren
APA
ELBARAZI, A., BADARY, O. A., ELMAZAR, M. M., & ELRASSAS, H. (2022). Cognitive Processing Therapy Versus Medication for the Treatment of Comorbid Substance Use Disorder and Post-Traumatic Stress Disorder in Egyptian patients (Randomized Clinical Trial). Journal of Evidence-Based Psychotherapies, 22(2), 63-90. https://doi.org/10.24193/jebp.2022.2.13
Vancouver
ELBARAZI A, BADARY OA, ELMAZAR MM, ELRASSAS H. Cognitive Processing Therapy Versus Medication for the Treatment of Comorbid Substance Use Disorder and Post-Traumatic Stress Disorder in Egyptian patients (Randomized Clinical Trial). Journal of Evidence-Based Psychotherapies. 2022;22(2):63-90. doi:10.24193/jebp.2022.2.13
BibTeX
@article{ELBARAZI2022,
author = {ELBARAZI, Amani and BADARY, Osama A. and ELMAZAR, Mohamed M. and ELRASSAS, Hanan},
title = {Cognitive Processing Therapy Versus Medication for the Treatment of Comorbid Substance Use Disorder and Post-Traumatic Stress Disorder in Egyptian patients (Randomized Clinical Trial)},
journal = {Journal of Evidence-Based Psychotherapies},
year = {2022},
volume = {22},
number = {2},
pages = {63--90},
doi = {10.24193/jebp.2022.2.13}
}
EUVIMED